BACKGROUND: To reduce the risk of adjustment problems associated with hematopoietic stem cell transplant (HSCT) for adolescents/young adults (AYAs), we examined efficacy of a therapeutic music video (TMV) intervention delivered during the acute phase of HSCT to: 1) increase protective factors of spiritual perspective, social integration, family environment, courageous coping, and hope-derived meaning; 2) decrease risk factors of illness-related distress and defensive coping; and 3) increase outcomes of self-transcendence and resilience. METHODS: This was a multisite randomized, controlled trial (COG-ANUR0631) conducted at 8 Children's Oncology Group sites involving 113 AYAs aged 11-24 years undergoing myeloablative HSCT. Participants, randomized to the TMV or low-dose control (audiobooks) group, completed 6 sessions over 3 weeks with a board-certified music therapist. Variables were based on Haase's Resilience in Illness Model (RIM). Participants completed measures related to latent variables of illness-related distress, social integration, spiritual perspective, family environment, coping, hope-derived meaning, and resilience at baseline (T1), postintervention (T2), and 100 days posttransplant (T3). RESULTS: At T2, the TMV group reported significantly better courageous coping (Effect Size [ES], 0.505; P = .030). At T3, the TMV group reported significantly better social integration (ES, 0.543; P = .028) and family environment (ES, 0.663; P = .008), as well as moderate nonsignificant effect sizes for spiritual perspective (ES, 0.450; P = .071) and self-transcendence (ES, 0.424; P = .088). CONCLUSIONS: The TMV intervention improves positive health outcomes of courageous coping, social integration, and family environment during a high-risk cancer treatment. We recommend the TMV be examined in a broader population of AYAs with high-risk cancers.
RCT Entities:
BACKGROUND: To reduce the risk of adjustment problems associated with hematopoietic stem cell transplant (HSCT) for adolescents/young adults (AYAs), we examined efficacy of a therapeutic music video (TMV) intervention delivered during the acute phase of HSCT to: 1) increase protective factors of spiritual perspective, social integration, family environment, courageous coping, and hope-derived meaning; 2) decrease risk factors of illness-related distress and defensive coping; and 3) increase outcomes of self-transcendence and resilience. METHODS: This was a multisite randomized, controlled trial (COG-ANUR0631) conducted at 8 Children's Oncology Group sites involving 113 AYAs aged 11-24 years undergoing myeloablative HSCT. Participants, randomized to the TMV or low-dose control (audiobooks) group, completed 6 sessions over 3 weeks with a board-certified music therapist. Variables were based on Haase's Resilience in Illness Model (RIM). Participants completed measures related to latent variables of illness-related distress, social integration, spiritual perspective, family environment, coping, hope-derived meaning, and resilience at baseline (T1), postintervention (T2), and 100 days posttransplant (T3). RESULTS: At T2, the TMV group reported significantly better courageous coping (Effect Size [ES], 0.505; P = .030). At T3, the TMV group reported significantly better social integration (ES, 0.543; P = .028) and family environment (ES, 0.663; P = .008), as well as moderate nonsignificant effect sizes for spiritual perspective (ES, 0.450; P = .071) and self-transcendence (ES, 0.424; P = .088). CONCLUSIONS: The TMV intervention improves positive health outcomes of courageous coping, social integration, and family environment during a high-risk cancer treatment. We recommend the TMV be examined in a broader population of AYAs with high-risk cancers.
Keywords:
adolescents; cancer; courageous coping; family relations; music; music therapy; resilience; self-transcendence; social environment; young adult
Authors: M J Kupst; B Penati; B Debban; B Camitta; D Pietryga; D Margolis; K Murray; J Casper Journal: Bone Marrow Transplant Date: 2002-11 Impact factor: 5.483
Authors: Fausto R Loberiza; J Douglas Rizzo; Christopher N Bredeson; Joseph H Antin; Mary M Horowitz; Jane C Weeks; Stephanie J Lee Journal: J Clin Oncol Date: 2002-04-15 Impact factor: 44.544
Authors: Joan E Haase; Eileen K Kintner; Sheri L Robb; Timothy E Stump; Patrick O Monahan; Celeste Phillips; Kristin A Stegenga; Debra S Burns Journal: Cancer Nurs Date: 2017 Nov/Dec Impact factor: 2.592
Authors: Terrah Foster Akard; Mary S Dietrich; Debra L Friedman; Pamela S Hinds; Barbara Given; Sarah Wray; Mary Jo Gilmer Journal: Pediatr Blood Cancer Date: 2015-01-13 Impact factor: 3.167
Authors: Amanda K Henley; Elizabeth Collier; Kim Robertson; Marial A Biard; Kathryn Bruno; Hannah Bush; Erinn Frees; Caitlin Krater; Sarah Woolever; Debra S Burns; Sheri L Robb Journal: J Music Ther Date: 2020-07-18
Authors: Joan E Haase; Sheri L Robb; Debra S Burns; Kristin Stegenga; Brooke Cherven; Verna Hendricks-Ferguson; Lona Roll; Sharron L Docherty; Celeste Phillips Journal: J Music Ther Date: 2020-02-25
Authors: Casey A Walsh; Jean C Yi; Abby R Rosenberg; Marie-Laure V Crouch; Wendy M Leisenring; Karen L Syrjala Journal: Psychooncology Date: 2020-08-13 Impact factor: 3.894
Authors: Germán Velez-Florez; María Camila Velez-Florez; Jose Oscar Mantilla-Rivas; Liliana Patarroyo-Rodríguez; Rodrigo Borrero-León; Santiago Rodríguez-León Journal: Curr Psychiatry Rep Date: 2018-07-21 Impact factor: 5.285
Authors: Abby R Rosenberg; Karen L Syrjala; Paul J Martin; Mary E Flowers; Paul A Carpenter; Rachel B Salit; K Scott Baker; Stephanie J Lee Journal: Cancer Date: 2015-08-19 Impact factor: 6.860
Authors: Yvonne Tran Bui; Matthew A Hathcock; Roberto P Benzo; Marie M Budev; Satish Chandrashekaran; David B Erasmus; Erika D Lease; Deborah J Levine; Karin L Thompson; Bradley K Johnson; Sheila G Jowsey-Gregoire; Cassie C Kennedy Journal: Clin Transplant Date: 2020-09-23 Impact factor: 2.863